Spontaneous Remission of Hodgkin's Lymphoma in a Patient with Systemic Lupus Erythematosus after Withdrawal of Methotrexate.
10.4078/jrd.2013.20.4.238
- Author:
Gu Min CHO
1
;
Myung Nam BAE
;
Young Hee JUNG
;
Hye Sun KANG
;
In Woon BAEK
;
Ki Jo KIM
;
Chul Soo CHO
Author Information
1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. md21c@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Hodgkin's lymphoma;
Methotrexate;
Systemic lupus erythematosus
- MeSH:
Abdomen;
Autoimmune Diseases;
Biopsy;
Female;
Hodgkin Disease;
Humans;
Lupus Erythematosus, Systemic;
Lymph Nodes;
Lymphatic Diseases;
Lymphocytes;
Lymphoproliferative Disorders;
Methotrexate;
Neck;
Remission, Spontaneous;
Thorax;
Young Adult
- From:Journal of Rheumatic Diseases
2013;20(4):238-242
- CountryRepublic of Korea
- Language:English
-
Abstract:
Methotrexate is often used in patients with systemic lupus erythematosus for effective disease controlsand steroid-sparing, and has been known to involve the development of lymphoproliferative disorders for patients with autoimmune diseases. We report a case of spontaneous regression of Epstein-Barr virus-positive methotrexate-associated Hodgkin's lymphoma in a 24-year-old woman with systemic lupus erythematosus. Following 6 months of treatment with low-dose methotrexate, the patient developed a neck mass in the right submandibular area. A computed tomography scan of the neck, chest and abdomen revealed multiple enlarged lymph nodes. Excisional biopsy of the neck masses confirmed infiltrations of malignant lymphoid cells that were positive for CD15, CD30, and Epstein-Barr virus-encoded RNA. Reduction of the mass was observed 3 weeks after withdrawing from the methotrexate treatment. At 7 months after initial presentation, computed tomography revealed near-complete regression of lymphadenopathy. After 30 months, the patient was still in complete clinical remission.
